Consolidated Statements of Cash Flow (USD $)	3 Months Ended		60 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
Cash Flows from Operating Activities
Net loss	$ (498,851)	$ (2,173,525)	$ (6,230,097)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	212	26	488
Stock based compensation	74,516	1,500,000	2,625,111
Impairment charges	0	0	2,662,000
Derivatives charges and credits	21,439	460,000	(1,538,267)
Changes in operating assets and liabilities
(Increase) in accounts receivable	16,005	0	(1,552)
(Increase) in inventories	8,555	0	(517,729)
(Increase) in deferred financing cost	34,000	0	34,000
(Increase) in prepaid expenses and other assets	(46,540)	(167,342)	(143,827)
Increase in accounts payable and accrued expenses	(129,507)	14,998	300,558
Net cash used in operating activities	(520,171)	(365,843)	(2,809,315)
Cash Flows from Investing Activities
Acquisition of intellectual property	0	(450,000)	(450,000)
Acquisition of fixed assets	(1,224)	(1,569)	(4,248)
Decrease in security deposits	10,000	0	10,000
Net cash used in investing activities	8,776	(451,569)	(444,248)
Cash Flows from Financing Activities
(Repayments to) advances from related parties	(53,139)	0	87,295
Repayment of notes payable	(350,000)	0	(742,500)
Insurance financing note	0	(10,487)	0
Offering costs	0	0	(45,000)
Proceeds from issuance of stock to initial stockholders	0	0	80,000
Proceeds from issuance of notes	0	0	540,000
Proceeds from private placement of common stock	1,025,000	1,427,256	3,505,500
Net cash provided by financing activities	621,861	1,416,769	3,425,295
Net increase in cash	110,466	599,357	171,732
Cash at beginning of the period	61,266	0	0
Cash at end of the period	171,732	599,357	171,732
Supplemental Disclosure of Cash Flow Information:
Cash paid for franchise taxes	1,550	800	2,350
Cash paid for interest	0	0	0
Supplemental Disclosure of Non-Cash Transactions:
Offering costs paid by stockholder	0	25,000	25,000
Conversion of stockholder loan into common stock		2,744	2,744
Conversion of stockholder loan into capital - no shares issued	0	22,256	22,256
Note payable - insurance financing	0	42,500	42,500
Note issued for accounts payable	0	0	7,500
Acquisition of intellectual property through note payable	0	700,000	700,000
Financing costs through issuance of restricted common stock	$ 0	$ 0	$ 60,000